or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    LBPH A Longboard Pharmaceuticals, Inc. 0.05
    LGND B Ligand Pharmaceuticals Incorporated 2.27
    SUPN C Supernus Pharmaceuticals, Inc. 1.12
    INCY C Incyte Corporation 1.89
    HCM D Hutchison China MediTech Limited -1.81
    HALO F Halozyme Therapeutics, Inc. 7.22
    BIIB F Biogen Idec Inc. -0.07
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    FBT C First Trust Amex Biotech Index Fund 10.36
    PBE C PowerShares Dynamic Biotech & Genome 9.98
    PJP C PowerShares Dynamic Pharmaceuticals 9.81
    BIS C ProShares UltraShort Nasdaq Biotechnology 9.05
    XPH B SPDR S&P Pharmaceuticals ETF 8.04
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare FBT to BIS Compare PBE to BIS Compare PJP to BIS

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        Nov 23 INCY What Moved Markets This Week
        Nov 22 HALO Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
        Nov 22 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why
        Nov 22 HALO Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
        Nov 22 HALO Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal
        Nov 22 HALO Halozyme withdraws $2.1 billion buyout offer for Evotec
        Nov 22 HALO Halozyme gains after withdrawing Evotec bid
        Nov 22 HALO Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
        Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
        Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
        Nov 22 INCY Goldman Sachs: Incyte Corporation (INCY) Is A Top Growth Investor Stock
        Nov 22 HALO Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
        Nov 21 INCY Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 HALO Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
        Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
        Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
        Nov 19 INCY Sector Update: Health Care Stocks Decline
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags